Wednesday, June 10, 2026

Patent intelligence · US

US 2014335071

Composition Exhibiting a von Willebrand Factor (vWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence AAGGILHLE…

granted A61K 35/ 14 A IA61K/384886A61P/702A61P/900
Status granted
Linked drugs 2
Pipeline programs 6
Years to expiry 8
Applicant portfolio 1
Patent details — US 2014335071
Jurisdiction
US
Status
granted
Grant date
Nov 13, 2014
Expiration
Nov 8, 2034
CPC classes
A61K 35/ 14 A I, A61K/384886, A61P/702, A61P/900
View on Google Patents ↗

Quick answer

US 2014335071 (Composition Exhibiting a von Willebrand Factor (vWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence AAGGILHLELLV) is held by BAXTER INNOVATIONS GMBH [AT]. Status: granted. Granted Nov 13, 2014. Expires Nov 8, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
CPC classes
A61K 35/ 14 A I, A61K/384886, A61P/702, A61P/900

Frequently asked questions

What is US patent 2014335071?

US 2014335071 (Composition Exhibiting a von Willebrand Factor (vWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence AAGGILHLELLV) is held by BAXTER INNOVATIONS GMBH [AT]. Status: granted. Granted Nov 13, 2014. Expires Nov 8, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 2014335071?

BAXTER INNOVATIONS GMBH [AT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 1 pharmaceutical patents for this assignee.

When does US 2014335071 expire?

Our index shows an expiration date of Nov 8, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.